Journal article

A single-chain derivative of the relaxin hormone is a functionally selective agonist of the G protein-coupled receptor, RXFP1

Chemical science, 2016 Jun 1. Hossain MA, Kocan M, Yao ST and 11 others.

Study type

Journal article

Subjects

Not classified in PubMed MeSH

Journal

Chemical science

Published

2016 Jun 1

PubMed

PMID 30155023 ↗

DOI

10.1039/c5sc04754d ↗

Full text

Free on PubMed Central (PMC6013806) ↗

Where PepCue cites this

This paper is part of the evidence base behind this profile. Citing a study is not an endorsement of the compound: papers that found no effect are indexed the same way.

B7-33 →

Other papers on B7-33

Randomized controlled trial · 2025

End-organ protective effect of serelaxin in patients hospitalized for heart failure: Results of the biomarker substudy of Relaxin in Acute Heart Failure-2 (RELAX-AHF-2)

Review · 2024

Relaxin agonists under preclinical and early clinical investigation for the treatment of heart failure

Journal article · 2023

The single-chain relaxin mimetic, B7-33, maintains the cardioprotective effects of relaxin and more rapidly reduces left ventricular fibrosis compared to perindopril in an experimental model of cardiomyopathy

PepCue indexes citation metadata only and does not reproduce abstracts or full text. Read the paper at the source links above. Nothing here is medical advice or a dose recommendation.

Educational and research reference only. Not medical advice, diagnosis, or dosing guidance. Flag an error on this page